+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Overactive Bladder Treatment Market Size, Share & Trends Analysis Report, Type (Anticholinergics, Mirabegron, Neuromodulation, Botox), Disease Type (Idiopathic, Neurogenic), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 100 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5921084
Description Jump to:
The global overactive bladder treatment market size is expected to reach USD 5.25 billion by 2030, and is estimated to register a CAGR of 4.8% over the forecast period. Factors such as the growing awareness about the overactive bladder (OAB) condition, along with rising R&D investments to develop novel formulations for this disease, are projected to drive the global market. In addition, rising competition owing to high demand for OAB medications and treatments and rising emphasis of major players to manufacture drugs is another vital factor propelling the demand forward.

Rising awareness about OAB and urinary incontinence among the population is one of the major factors bolstering the growth of the market. Various key players operating in the industry undertake numerous initiatives to raise awareness about the overactive bladder condition. For instance, in January 2023, Urovant Sciences, a key player operating in the market, collaborated with actress and patient Holly Robinson Peete under a campaign to bring awareness to OAB. Such initiatives help increase awareness and knowledge about the treatment options thereby increasing treatment adoption.

Moreover, increasing investments to develop innovative formulations and treatments targeting OAB are anticipated to fuel growth over the forecast period. For instance, in November 2019, EBT Medical, Inc., a startup, received funding of USD 10 million in series A for developing noninvasive neuromodulation technology to treat overactive bladder. Thus, developments and investments focusing on medications and treatments are anticipated to fuel the geographic expansion.

Furthermore, industry participants are undertaking various strategies like collaborations and new product launches to maintain their position in this competitive market. For instance, in March 2023, KYORIN Pharmaceutical Co., Ltd. collaborated with Sumitomo Pharma Co., Ltd. to develop, manufacture, and commercialize Vibegron for OAB in Taiwan and other Asian Countries like Singapore, Hong Kong, Indonesia, and Vietnam. Such collaborations among major players are expected to increase the accessibility of drugs and treatments across the countries, which can further propel growth in the coming years.

Overactive Bladder Treatment Market Report Highlights

  • Mirabegron drug dominated the market in 2023 with a which can be attributed to the high adoption and prescription rate of Mirabegron for treating OAB
  • Among disease-type segments, the idiopathic overactive bladder segment was the largest revenue contributor for the industry in 2023 due to its high prevalence rate
  • In the distribution channel segment, the retail pharmacies dominated the market. The higher revenue growth is attributed to the presence of established retail pharmacies offering OAB drugs and its better patient compatibility
  • North America dominated the market for overactive bladder treatment in 2023 owing to the presence of key players such as Pfizer, Inc., AbbVie, Inc., and Viatris, Inc. across the region

Table of Contents

Chapter 1. Methodology and Scope
1.1. Segment Definitions
1.1.1. Product Segment
1.1.2. Strength Segment
1.1.3. Distribution Channel Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.12. Research Assumptions
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of target diseases
3.2.1.2. Rising R&D investments for introducing new treatments
3.2.1.3. Growing awareness about the condition
3.2.2. Market Restraint Analysis
3.2.2.1. Adverse effects associated with medications and treatment.
3.2.2.2. Increasing product recalls
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Overactive Bladder Treatment Market: Type Movement Analysis
4.2. Anticholinergics
4.2.1. Anticholinergics Market, 2018-2030 (USD Million)
4.3. Mirabegron
4.3.1. Mirabegron Market, 2018-2030 (USD Million)
4.4. Botox
4.4.1. Botox Market, 2018-2030 (USD Million)
4.5. Neuromodulation
4.5.1. Neuromodulation Market, 2018-2030 (USD Million)
4.6. Others
4.6.1. Other Types Market, 2018-2030 (USD Million)
Chapter 5. Disease Type Business Analysis
5.1. Overactive Bladder Treatment Market: Disease Type Movement Analysis
5.2. Idiopathic Overactive Bladder
5.2.1. Idiopathic Overactive Bladder Market, 2018-2030 (USD Million)
5.3. Neurogenic Overactive Bladder
5.3.1. Neurogenic Overactive Bladder Market, 2018-2030 (USD Million)
Chapter 6. Distribution Channel Business Analysis
6.1. Overactive Bladder Treatment Market: Distribution Channel Movement Analysis
6.2. Hospital Pharmacies
6.2.1. Hospital Pharmacies Market, 2018-2030 (USD Million)
6.3. Retail Pharmacies
6.3.1. Retail Pharmacies Market, 2018-2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018-2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Overactive Bladder Treatment Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Reimbursement Scenario
7.2.2.5. U.S. Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Reimbursement Scenario
7.2.3.5. Canada Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Scenario
7.3.2.5. UK Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Scenario
7.3.3.5. Germany Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Scenario
7.3.4.5. France Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Scenario
7.3.5.5. Italy Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Scenario
7.3.6.5. Spain Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Reimbursement Scenario
7.3.7.5. Denmark Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Reimbursement Scenario
7.3.8.5. Sweden Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Reimbursement Scenario
7.3.9.5. Norway Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Scenario
7.4.2.5. Japan Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Scenario
7.4.3.5. China Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Scenario
7.4.4.5. India Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Reimbursement Scenario
7.4.5.5. Australia Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Reimbursement Scenario
7.4.6.5. Thailand Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Reimbursement Scenario
7.4.7.5. South Korea Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Scenario
7.5.2.5. Brazil Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Scenario
7.5.3.5. Mexico Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Scenario
7.5.4.5. Argentina Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.6. MEA
7.6.1. MEA Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Scenario
7.6.2.5. South Africa Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Scenario
7.6.3.5. Saudi Arabia Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Scenario
7.6.4.5. UAE Overactive Bladder Treatment Market, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Scenario
7.6.5.5. Kuwait Overactive Bladder Treatment Market, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Pfizer, Inc
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. AbbVie Inc.
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Astellas Pharma Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Medtronic
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Sumitomo Pharma America, Inc.( Urovant Sciences.)
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Viatris Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Teva Pharmaceutical Industries Ltd.
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Hisamitsu Pharmaceutical Co., Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Macleods Pharmaceuticals Ltd.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Endo International plc
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 4 Global Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 5 Global Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 6 Global Overactive Bladder Treatment Market, By Region, 2018-2030 (USD Million)
TABLE 7 North America Overactive Bladder Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 8 North America Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 9 North America Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 10 North America Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 11 U.S. Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 12 U.S. Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 13 U.S. Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 14 Canada Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 15 Canada Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 16 Canada Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 17 Europe Overactive Bladder Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 18 Europe Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 19 Europe Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 20 Europe Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 21 UK Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 22 UK Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 23 UK Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 24 Germany Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 25 Germany Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 26 Germany Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 27 France Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 28 France Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 29 France Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 30 Spain Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 31 Spain Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 32 Spain Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 33 Italy Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 34 Italy Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 35 Italy Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 36 Denmark Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 37 Denmark Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 38 Denmark Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 39 Norway Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 40 Norway Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 41 Norway Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 42 Sweden Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 43 Sweden Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 44 Sweden Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 45 Asia-Pacific Overactive Bladder Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 46 Asia-Pacific Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 47 Asia-Pacific Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 48 Asia-Pacific Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 49 China Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 50 China Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 51 China Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 52 Japan Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 53 Japan Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 54 Japan Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 55 India Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 56 India Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 57 India Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 58 South Korea Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 59 South Korea Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 60 South Korea Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 61 Australia Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 62 Australia Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 63 Australia Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 64 Thailand Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 65 Thailand Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 66 Thailand Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 67 Latin America Overactive Bladder Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 68 Latin America Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 69 Latin America Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 70 Latin America Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 71 Brazil Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 72 Brazil Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 73 Brazil Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 74 Mexico Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 75 Mexico Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 76 Mexico Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 77 Argentina Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million),
TABLE 78 Argentina Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 79 Argentina Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 80 MEA Overactive Bladder Treatment Market, By Country, 2018-2030 (USD Million)
TABLE 81 MEA Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 82 MEA Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 83 MEA Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 84 South Africa Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 85 South Africa Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 86 South Africa Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 87 UAE Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 88 UAE Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 89 UAE Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 90 Saudi Arabia Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million),
TABLE 91 Saudi Arabia Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 92 Saudi Arabia Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
TABLE 93 Kuwait Overactive Bladder Treatment Market, By Type, 2018-2030 (USD Million)
TABLE 94 Kuwait Overactive Bladder Treatment Market, By Disease Type, 2018-2030 (USD Million)
TABLE 95 Kuwait Overactive Bladder Treatment Market, By Distribution Channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Overactive bladder treatment market segmentation
Figure 8 Market snapshot, 2023
Figure 9 Market trends & outlook
Figure 10 Market driver relevance analysis (current & future impact)
Figure 11 Market restraint relevance analysis (current & future impact)
Figure 12 PESTEL analysis
Figure 13 Porter’s five forces analysis
Figure 14 Global overactive bladder treatment market: Type outlook and key takeaways
Figure 15 Global overactive bladder treatment market: Type movement analysis
Figure 16 Global overactive bladder treatment market, for anticholinergics, 2018-2030 (USD Million)
Figure 17 Global overactive bladder treatment market, for mirabegron, 2018-2030 (USD Million)
Figure 18 Global overactive bladder treatment market, for Botox, 2018-2030 (USD Million)
Figure 19 Global overactive bladder treatment market, for neuromodulation, 2018-2030 (USD Million)
Figure 20 Global overactive bladder treatment market, for other types, 2018-2030 (USD Million)
Figure 21 Global overactive bladder treatment market: Disease type outlook and key takeaways
Figure 22 Global overactive bladder treatment market: Disease type movement analysis
Figure 23 Global overactive bladder treatment market, for idiopathic overactive bladder, 2018-2030 (USD Million)
Figure 24 Global overactive bladder treatment market, for neurogenic overactive bladder, 2018-2030 (USD Million)
Figure 25 Global overactive bladder treatment market: Distribution channel outlook and key takeaways
Figure 26 Global overactive bladder treatment market: Distribution channel movement analysis
Figure 27 Global overactive bladder treatment market, for hospital pharmacy, 2018-2030 (USD Million)
Figure 28 Global overactive bladder treatment market, for retail pharmacy, 2018-2030 (USD Million)
Figure 29 Global overactive bladder treatment market, for others, 2018-2030 (USD Million)
Figure 30 Regional marketplace: Key takeaways
Figure 31 Regional outlook, 2022 & 2030
Figure 32 Global overactive bladder treatment market: Region movement analysis
Figure 33 North America overactive bladder treatment market, 2018-2030 (USD Million)
Figure 34 U.S overactive bladder treatment market, 2018-2030 (USD Million)
Figure 35 Canada overactive bladder treatment market, 2018-2030 (USD Million)
Figure 36 Europe overactive bladder treatment market, 2018-2030 (USD Million)
Figure 37 Germany overactive bladder treatment market, 2018-2030 (USD Million)
Figure 38 U.K overactive bladder treatment market, 2018-2030 (USD Million)
Figure 39 France overactive bladder treatment market, 2018-2030 (USD Million)
Figure 40 Italy overactive bladder treatment market, 2018-2030 (USD Million)
Figure 41 Spain overactive bladder treatment market, 2018-2030 (USD Million)
Figure 42 Denmark overactive bladder treatment market, 2018-2030 (USD Million)
Figure 43 Sweden overactive bladder treatment market, 2018-2030 (USD Million)
Figure 44 Norway overactive bladder treatment market, 2018-2030 (USD Million)
Figure 45 Asia-Pacific overactive bladder treatment market, 2018-2030 (USD Million)
Figure 46 Japan overactive bladder treatment market, 2018-2030 (USD Million)
Figure 47 China overactive bladder treatment market, 2018-2030 (USD Million)
Figure 48 India overactive bladder treatment market, 2018-2030 (USD Million)
Figure 49 Australia overactive bladder treatment market, 2018-2030 (USD Million)
Figure 50 South Korea overactive bladder treatment market, 2018-2030 (USD Million)
Figure 51 Thailand overactive bladder treatment market, 2018-2030 (USD Million)
Figure 52 Latin America overactive bladder treatment market, 2018-2030 (USD Million)
Figure 53 Brazil overactive bladder treatment market, 2018-2030 (USD Million)
Figure 54 Mexico overactive bladder treatment market, 2018-2030 (USD Million)
Figure 55 Argentina overactive bladder treatment market, 2018-2030 (USD Million)
Figure 56 Middle East and Africa overactive bladder treatment market, 2018-2030 (USD Million)
Figure 57 South Africa overactive bladder treatment market, 2018-2030 (USD Million)
Figure 58 Saudi Arabia overactive bladder treatment market, 2018-2030 (USD Million)
Figure 59 UAE overactive bladder treatment market, 2018-2030 (USD Million)
Figure 60 Kuwait overactive bladder treatment market, 2018-2030 (USD Million)

Companies Mentioned

  • Pfizer, Inc
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Medtronic
  • Sumitomo Pharma America, Inc.( Urovant Sciences.)
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Macleods Pharmaceuticals Ltd.
  • Endo International plc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedDecember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 3.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.25 Billion
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Overactive Bladder Treatment Market by Drug Therapy, Disease Type, Distribution - Global Forecast 2025-2030 - Product Image

Overactive Bladder Treatment Market by Drug Therapy, Disease Type, Distribution - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Overactive Bladder Treatment Global Market Report 2024 - Product Image

Overactive Bladder Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report - Product Image

Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Overactive Bladder Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Overactive Bladder Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 96 Pages
  • Global
From
Pediatric Bladder Treatment Global Market Report 2024 - Product Image

Pediatric Bladder Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.